File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Clinical and angiographic outcome of intracranial aneurysms treated with Matrix detachable coils in Chinese patients

TitleClinical and angiographic outcome of intracranial aneurysms treated with Matrix detachable coils in Chinese patients
Authors
KeywordsEmbolization
Intracranial aneurysm
Matrix detachable coil
Outcome
Issue Date2007
Citation
Surgical Neurology, 2007, v. 67, n. 2, p. 122-126 How to Cite?
AbstractBackground: Aneurysm recurrence is an innate problem in endovascular treatment of aneurysms with coils. A coated coil system named Matrix (Boston Scientific Neurovascular, Fremont, CA), covered with a bioabsorbable polymeric material (polyglycolide/lactide copolymer [PGLA]), was developed to accelerate intraaneurysmal clot organization and fibrosis. The purpose of this study was to evaluate the efficacy and safety of the Matrix detachable coils in patients with intracranial aneurysms and aneurysmal recurrence rate. Methods: In a regional neurosurgical center in Hong Kong, data of patients undergoing endovascular embolization of intracranial aneurysm was collected. In a 20-month period, 42 patients with 44 aneurysms were treated by endovascular embolization using matrix coils alone or mixed with bare platinum coils. Thirty-four patients presented with ruptured aneurysms, and 8 patients presented with unruptured aneurysms. Results: Twenty-five patients (60%) had 6-month follow-up DSA, and 10 patients (24%) had 18-month follow-up DSA. Seven aneurysm recurrences were identified, amounting to 16% for all aneurysms and 14% for ruptured aneurysms. Four patients were treated by repeated embolization, and 2 patients were treated by microsurgical clipping. Two adverse events due to thromboembolism were noted. One 78-year-old lady with poor-grade subarachnoid hemorrhage treated by partial embolization died from rebleed at day 4. Another patient with partial embolization and spontaneous thrombosis of dorsal wall ICA aneurysm died at 2 months with aneurysm recanalization with rerupture. Twenty-six patients achieved favorable outcome (GOS score 4 or 5) at last follow-up. The aneurysm recurrence rate using bare platinum coils of the same center was 11% and 7% for all aneurysms and ruptured aneurysms, respectively. Conclusion: Matrix coil embolization was safe, but there was no reduction in aneurysm recurrence using matrix coils alone or mixed with GDCs, compared with GDCs alone. © 2007 Elsevier Inc. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/325134
ISSN
2011 Impact Factor: 1.669
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorWong, George K.C.-
dc.contributor.authorYu, Simon C.H.-
dc.contributor.authorPoon, W. S.-
dc.date.accessioned2023-02-27T07:30:01Z-
dc.date.available2023-02-27T07:30:01Z-
dc.date.issued2007-
dc.identifier.citationSurgical Neurology, 2007, v. 67, n. 2, p. 122-126-
dc.identifier.issn0090-3019-
dc.identifier.urihttp://hdl.handle.net/10722/325134-
dc.description.abstractBackground: Aneurysm recurrence is an innate problem in endovascular treatment of aneurysms with coils. A coated coil system named Matrix (Boston Scientific Neurovascular, Fremont, CA), covered with a bioabsorbable polymeric material (polyglycolide/lactide copolymer [PGLA]), was developed to accelerate intraaneurysmal clot organization and fibrosis. The purpose of this study was to evaluate the efficacy and safety of the Matrix detachable coils in patients with intracranial aneurysms and aneurysmal recurrence rate. Methods: In a regional neurosurgical center in Hong Kong, data of patients undergoing endovascular embolization of intracranial aneurysm was collected. In a 20-month period, 42 patients with 44 aneurysms were treated by endovascular embolization using matrix coils alone or mixed with bare platinum coils. Thirty-four patients presented with ruptured aneurysms, and 8 patients presented with unruptured aneurysms. Results: Twenty-five patients (60%) had 6-month follow-up DSA, and 10 patients (24%) had 18-month follow-up DSA. Seven aneurysm recurrences were identified, amounting to 16% for all aneurysms and 14% for ruptured aneurysms. Four patients were treated by repeated embolization, and 2 patients were treated by microsurgical clipping. Two adverse events due to thromboembolism were noted. One 78-year-old lady with poor-grade subarachnoid hemorrhage treated by partial embolization died from rebleed at day 4. Another patient with partial embolization and spontaneous thrombosis of dorsal wall ICA aneurysm died at 2 months with aneurysm recanalization with rerupture. Twenty-six patients achieved favorable outcome (GOS score 4 or 5) at last follow-up. The aneurysm recurrence rate using bare platinum coils of the same center was 11% and 7% for all aneurysms and ruptured aneurysms, respectively. Conclusion: Matrix coil embolization was safe, but there was no reduction in aneurysm recurrence using matrix coils alone or mixed with GDCs, compared with GDCs alone. © 2007 Elsevier Inc. All rights reserved.-
dc.languageeng-
dc.relation.ispartofSurgical Neurology-
dc.subjectEmbolization-
dc.subjectIntracranial aneurysm-
dc.subjectMatrix detachable coil-
dc.subjectOutcome-
dc.titleClinical and angiographic outcome of intracranial aneurysms treated with Matrix detachable coils in Chinese patients-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.surneu.2006.05.063-
dc.identifier.pmid17254862-
dc.identifier.scopuseid_2-s2.0-33846307786-
dc.identifier.volume67-
dc.identifier.issue2-
dc.identifier.spage122-
dc.identifier.epage126-
dc.identifier.isiWOS:000244212200006-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats